Analyzing the impact of drug-related public policies on health and society
Official title: Universal Sensitivity Analysis for Unmeasured Confounding in Drug-Related Public Policy Evaluation
Funded at New York University · NIH-11070398 · Data updated 2026-11-12
This study is looking at how different rules about drugs like alcohol and tobacco affect people's health and finances, especially for different groups based on race and income, so that policymakers can make better choices based on clear information.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | April 15, 2024 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $241,194 |
| NIH project number | 5R21DA060433-02 |
| Project ID | NIH-11070398 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by drug-related policies, particularly those from diverse racial and socioeconomic backgrounds.
✕Less likely to help
Patients who are not impacted by drug-related policies or who do not engage with substances like alcohol or tobacco may not receive direct benefits from this research.
What this research studies
This research aims to develop a new framework for sensitivity analysis to better understand the effects of drug-related public policies, such as alcohol and tobacco regulations. By addressing unmeasured confounding factors, the project seeks to provide clearer insights into how these policies impact various outcomes, including health and economic factors. The approach involves analyzing data from matched observational studies, focusing on both binary and non-binary policy measures, and considering subgroup-specific effects based on race and socioeconomic status. This comprehensive analysis will help policymakers make informed decisions based on more accurate evidence.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug-related public policies that improve health outcomes and reduce disparities in drug use across different populations.
How similar studies have gone: While sensitivity analysis in public policy evaluation is a recognized area, this specific approach to drug-related policies is novel and has not been extensively tested in prior research.
Where this research is happening
-
New York University
New York, United States Active
Researchers
- Principal investigator: Heng, Siyu — New York University
- Study coordinator: Heng, Siyu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.